IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 28 filers reported holding IBERE PHARMACEUTICALS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,052,000 | -8.1% | 714,500 | -8.1% | 0.07% | -11.0% |
| Q1 2022 | $7,672,000 | -2.5% | 777,700 | -0.9% | 0.08% | +3.8% |
| Q4 2021 | $7,865,000 | -2.1% | 784,909 | -2.3% | 0.08% | -3.7% |
| Q3 2021 | $8,030,000 | -0.5% | 803,400 | 0.0% | 0.08% | +7.9% |
| Q2 2021 | $8,074,000 | +2.0% | 803,400 | +0.1% | 0.08% | 0.0% |
| Q1 2021 | $7,916,000 | – | 802,800 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |